PD-L1 agents in the treatment of NSCLC
The KEYNOTE-001 trial: A breakthrough for pembrolizumab
Immunotherapy in second-line treatment of non-small cell lung cancer
ESMO 2016: Press brief on results of trial of neoadjuvant chemotherapy in soft tissue sarcomas
Are bladder sparing procedures a real advancement in muscle invasive bladder cancer?